Amanote Research
Register
Sign In
Cytokines and Acute-Phase Serum Proteins as Markers of Inflammatory Regression During Pulmonary Tuberculosis Treatment
Journal of Venomous Animals and Toxins Including Tropical Diseases
- United Kingdom
doi 10.1590/s1678-91992008000100019
Full Text
Open PDF
Abstract
Available in
full text
Categories
Animal Science
Zoology
Parasitology
Infectious Diseases
Toxicology
Date
January 1, 2008
Authors
E. Peresi
Publisher
FapUNIFESP (SciELO)
Related search
Evaluation of Serum Inflammatory Biomarkers as Predictors of Treatment Outcome in Pulmonary Tuberculosis
International Journal of Tuberculosis and Lung Disease
Medicine
Pulmonary
Infectious Diseases
Respiratory Medicine
Appliance of Acute Phase Proteins, Cytokines, Biogram and Hemogram as Markers for Nanoparticles-Induced Clinicopathological Alterations
Biomedical Research
Substitution of Moxifloxacin for Isoniazid During Intensive Phase Treatment of Pulmonary Tuberculosis
American Journal of Respiratory and Critical Care Medicine
Pulmonary
Critical Care
Respiratory Medicine
Intensive Care Medicine
Pre-Treatment Serum Inflammatory Cytokines as Survival Predictors of Patients With Nasopharyngeal Carcinoma Receiving Chemoradiotherapy
Molecular and Clinical Oncology
Cancer Research
Oncology
Myelopathy During Treatment for Pulmonary Tuberculosis.
Postgraduate Medical Journal
Medicine
T-SPOT.TBresponses During Treatment of Pulmonary Tuberculosis
BMC Infectious Diseases
Infectious Diseases
Inflammatory Cytokines as Predictive Markers for Early Detection and Progression of Diabetic Nephropathy
EPMA Journal
Biochemistry
Health Policy
Drug Discovery
Multiple Inflammatory Cytokines Converge to Regulate CD8+T Cell Expansion and Function During Tuberculosis
Journal of Immunology
Allergy
Immunology
Acute Phase Proteins and Markers of Oxidative Stress to Assess the Severity of the Pulmonary Hypertension in Heartworm-Infected Dogs
Parasites and Vectors
Parasitology
Infectious Diseases
